Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma

Multiple myeloma (MM) has a five-year prevalence worldwide of 230,000 people and is known as the second most common hematological malignancy within the United States. Extensive research has been conducted to gain a wide range of treatment strategies, providing hope to these patients. Combination the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cureus
Prif Awduron: Padda, Jaskamal, Khalid, Khizer, Zubair, Ujala, Peethala, Mounika M, Kakani, Varsha, Goriparthi, Lakshmi, Almanie, Abdulelah H, Cooper, Ayden Charlene, Jean-Charles, Gutteridge
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Cureus 2021
Pynciau:
Internal Medicine
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310625/
https://ncbi.nlm.nih.gov/pubmed/34322356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15917
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg